• Info
  • Significant Ownership

Significant Ownership of Innovative Cellular Therapeutics Holdings Ltd

Signature - Title
/s/ Lei Xiao - Lei Xiao/ Chief Executive Officer
Location
George Town
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Innovative Cellular Therapeutics Holdings Ltd.

Notify me when Innovative Cellular Therapeutics Holdings Ltd files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Innovative Cellular Therapeutics Holdings Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LYEL Lyell Immunopharma, Inc. Common Stock, par value $0.0001 9.8% $30.9M 1.9M Innovative Cellular Therapeutics Holdings Ltd 06 Nov 2025

Schedules 13D/G Reported by Innovative Cellular Therapeutics Holdings Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.